Biblio

Found 9 results
Filters: Author is Caulin, Carlos  [Clear All Filters]
2024
Hao Q, Li R, Li H, Rui S, You L, Zhang L, Zhao Y, Li P, Li Y, Kong X et al..  2024.  Dynamics of The Γδtcr Repertoires During The Dedifferentiation Process and Pilot Implications for Immunotherapy of Thyroid Cancer.. Adv Sci (Weinh). :e2306364.
2023
Bauman JE, Saba NF, Roe D, Bauman JR, Kaczmar J, Bhatia A, Muzaffar J, Julian R, Wang S, Bearelly S et al..  2023.  Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.. J Clin Oncol. 41(22):3851-3862.
Yan H, Ma Y, Zhou X, He Y, Liu Y, Caulin C, Wang L, Xu H, Luo H.  2023.  Spontaneous Murine Model of Anaplastic Thyroid Cancer.. J Vis Exp. (192)
2022
Luo H, Xia X, Bin Huang L-, An H, Cao M, Kim GDae, Chen H-N, Zhang W-H, Shu Y, Kong X et al..  2022.  Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment.. Nat Commun. 13(1):6619.
2021
Luo H, Xia X, Kim GDae, Liu Y, Xue Z, Zhang L, Shu Y, Yang T, Chen Y, Zhang S et al..  2021.  Characterizing dedifferentiation of thyroid cancer by integrated analysis.. Sci Adv. 7(31)
Wang J, Hu Y, Escamilla-Rivera V, Gonzalez CL, Tang L, Wang B, El-Naggar AK, Myers JN, Caulin C.  2021.  Epithelial Mutant p53 Promotes Resistance to Anti-PD-1-Mediated Oral Cancer Immunoprevention in Carcinogen-Induced Mouse Models.. Cancers (Basel). 13(6)
Centuori SM, Caulin C, Bauman JE.  2021.  Precision and Immunoprevention Strategies for Tobacco-Related Head and Neck Cancer Chemoprevention.. Curr Treat Options Oncol. 22(6):52.
2020
Chari NS, Ivan C, Le X, Li J, Mijiti A, Patel AA, Osman AA, Peterson CB, Williams MD, Pickering CR et al..  2020.  Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer.. J Natl Cancer Inst. 112(3):266-277.
2017
Wang J, Xie T, Wang B, William WN, Heymach JV, El-Naggar AK, Myers JN, Caulin C.  2017.  PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions.. Cancer Prev Res (Phila). 10(12):684-693.